What Is/Charitable Organization/Orlando/Type None Diabetes
Here you can find the full list of Credits http://broadcaster.beazil.net/public/credits/youtube/videos/42438 The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested nearly $2 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities; collaborating regionally for efficiency and broader fundraising impact; and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers in more than 100 locations throughout the United States and our 6 international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. In type 1 diabetes, the pancreas, a large gland behind the stomach, stops making insulin because the cells that make the insulin have been destroyed by the body’s immune system. Without insulin, the body’s cells cannot turn glucose (sugar), into energy.
People with type 1 diabetes depend on insulin every day of their lives to replace the insulin the body cannot produce. They must test their blood glucose levels several times throughout the day.
The onset of type 1 diabetes typically occurs in people under 30 years, but can occur at any age. About 10-15% of all cases of diabetes are type 1.
Without insulin the body burns its own fats as a substitute which releases chemical substances in the blood. Without ongoing injections of insulin, the dangerous chemical substances will accumulate and can be life threatening if it is not treated. This is a condition call ketoacidosis. The final variation has the city named after the protagonist in the Shakespeare play As You Like It. In 1975, Judge Donald A. Cheney put forth a new version of the story in an Orlando Sentinel article. Cheney (a local historian and then chairman of the county historical commission) recounted a story told to him by his father, Judge John Moses Cheney (a major figure in Orlando’s history who arrived in Orlando in 1885). The elder Cheney recounted that another gentleman at that time, James Speer, proposed the name Orlando after the character in As You Like It. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
All in all, it was all about –
Diabetes and Pregnancy,beta cells release insulin,gestational diabetes mellitus,Hypers,interstitial glucose,volunteering,noninsulin monotherapy,injection site rotation,Levemir,CONCEPTT,brittle diabetes,latent autoimmune diabetes in adults,scientific community,Government Advocacy,Somogyi effect,reality of T1D,support,TRIAD study,Greater Louisville Walk,ADA,ketone,Betta Cells,diabetic kidney disease,plasma glucose criteria,Diet,Ketoacidosis,Political advocacy,The Kumamoto Study,donate,Prevent Autoimmunity,diabetes risk assessment,World without T1D,Type 1 Diabetes,Prevention of diabetes complications,juvenile diabetes,Insulin,Cure,TypeOneNation,Abstracts of JDRF Research,diabetes related complications,diabetes educator,secondary diabetes,Grassroots fundraising,Ride to Cure Diabetes,tolbutamide,Glucose Modulating Agents,Severe hypoglycemia,gestational diabetes,Type 1,NDEP,CGM,Chapter Volunteer Outreach Chairs,VLDL cholesterol,Insulin Pump,cure therapies,Weight Loss Support,Humulin R,diabetes diarrhea,starch breakdown,Cost of insulin,Trial,life-changing breakthroughs,treatment of diabetes,insulin reaction,Managing a hypo,early detection of diabetes,preprandial blood.